Behçet's syndrome

Best Practice and Research: Clinical Rheumatology

Volumn 22, Issue 5, 2008, Pages 793-809

  Yurdakul, Sebahattin ^b   Yazici, Hasan ^a  

^a ISTANBUL UNIVERSITY   (Turkey)

^b NONE

Author keywords

arthritis; Beh et's disease; Beh et's syndrome; genital ulcer; HLA B51; pathergy; recurrent oral ulceration; thrombophlebitis; vasculitis

Indexed keywords

ACICLOVIR; ALPHA INTERFERON; ALPHA2A INTERFERON; ANTINUCLEAR ANTIBODY; AZAPROPAZONE; AZATHIOPRINE; C REACTIVE PROTEIN; CARDIOLIPIN ANTIBODY; CD4 ANTIGEN; COLCHICINE; CYCLOPHOSPHAMIDE; CYCLOSPORIN; CYTOKINE; DACLIZUMAB; DAPSONE; ETANERCEPT; INFLIXIMAB; METHYLPREDNISOLONE; METHYLPREDNISOLONE ACETATE; NEUTROPHIL CYTOPLASMIC ANTIBODY; PLACEBO; RHEUMATOID FACTOR; SALAZOSULFAPYRIDINE; THALIDOMIDE; TRANSFER FACTOR;

ACNE; ALOPECIA; ARTHRALGIA; AUTOINFLAMMATORY DISEASE; BEHCET DISEASE; CARDIOVASCULAR DISEASE; CENTRAL NERVOUS SYSTEM DISEASE; CEREBRAL SINUS THROMBOSIS; CLINICAL FEATURE; CLINICAL TRIAL; CLUSTER ANALYSIS; DEEP VEIN THROMBOSIS; DEPRESSION; DIFFERENTIAL DIAGNOSIS; DISEASE ASSOCIATION; DRUG WITHDRAWAL; ENTERITIS; ENTHESITIS; ENVIRONMENTAL FACTOR; EYE DISEASE; FEVER; FLU LIKE SYNDROME; GASTROINTESTINAL DISEASE; HEREDITY; HUMAN; HYPERTENSION; INFECTION; INJECTION SITE REACTION; LEUKOPENIA; LOW DRUG DOSE; MUSCULOSKELETAL DISEASE; NEPHROTOXICITY; NEUROLOGIC DISEASE; NEUROTOXICITY; PERIPHERAL VEIN; POLYNEUROPATHY; PRIORITY JOURNAL; PROGNOSIS; REACTIVE ARTHRITIS; REVIEW; SINGLE DRUG DOSE; SKIN DISEASE; SOMNOLENCE; TERATOGENICITY; TUBERCULOSIS;

BEHCET SYNDROME; FEMALE; HUMANS; MALE; PREVALENCE;

EID: 56349120677     PISSN: 15216942     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.berh.2008.08.005     Document Type: Review

References (98)

1. Behçet H. Uber rezidivierende, aphthose, dürch ein Virus verursachte Geshwure am Munde, am Auge und an den Genitalien. Dermatologische Wochenschrift 36 (1937) 1152-1157
2. Sakane T., Takeno M., Suzuki N., and Inaba G. Behcet's disease. The New England Journal of Medicine 41 (1999) 1284-1291
3. Yurdakul S., Hamuryudan V., Fresko I., and Yazi{dotless}ci{dotless} H. Behçet's syndrome. In: Hochberg M.C., Silman A.J., Smolen Y.S., et al. (Eds). Rheumatology. 4th edn. (2008), Mosby Elsevier, Philadelphia 1561-1565
4. Verity D.H., Marr J.E., Ohno S., et al. Behçet's disease, the Silk Road and HLA-B51: historical and geographical perspectives. Tissue Antigens 54 (1999) 213-220
5. Demirhindi O., Yazici H., Binyildiz P., et al. Silivri Fener koyu ve yoresinde Behçet hastaligi sikligi ve bu hastaligin toplum icinde taranabilmesinde kullanabilecek bir yontem. Cerrahpaşa Tip Fakültesi Dergisi 12 (1981) 509-514 [in Turkish]
6. Yurdakul S., Gunaydin I., Tuzun Y., et al. The prevalence of Behçet's syndrome in a rural area in northern Turkey. The Journal of Rheumatology 15 (1988) 820-822
7. Idil A., Gurler A., Boyvat A., et al. The prevalence of Behçet's disease above the age of 10 years. The results of a pilot study conducted at the Park Primary Health Care Center in Ankara, Turkey. Ophthalmic Epidemiology 9 (2002) 325-331
8. Azizlerli G., Kose A.A., Sarica R., et al. Prevalence of Behçet's disease in Istanbul, Turkey. International Journal of Dermatology 42 (2003) 803-806
9. Cakir N., Dervis E., Benian O., et al. Prevalence of Behçet's disease in rural western Turkey: a preliminary report. Clinical and Experimental Rheumatology 22 4 Suppl. 34 (2004) S53-S55
10. Ozen S., Karaaslan Y., Ozdemir O., et al. Prevalence of juvenile chronic arthritis and familial Mediterranean fever in Turkey: a field study. The Journal of Rheumatology 25 (1998) 2445-2449
11. Yamamoto S., Toyokawa H., Matsubara J., et al. A nation wide survey of Behçet's disease in Japan. Japanese Journal of Ophthalmology 18 (1974) 282-290
12. Hirohata T., Kuratsune M., Nomura A., and Jimi S. Prevalence of Behçet's syndrome in Hawai. Hawaii Medical Journal 34 (1975) 244-246
13. Chamberlain M.A. Behçet's syndrome in 32 patients in Yorkshire. Annals of the Rheumatic Diseases 36 (1977) 491-499
14. Gonzalez-Gay M.A., Garcia-Porrua C., Branas F., et al. Epidemiologic and clinical aspects of Behçet's disease in a defined area of Northwestern Spain, 1988-1997. The Journal of Rheumatology 27 (2000) 703-707
15. Graña J., Sánchez-Meizoso M.O., and Galdo F. Epidemiological aspects of Behçet's disease in Galicia. The Journal of Rheumatology 28 (2001) 2565-2566
16. Mok C.C., Cheung T.C., Ho C.T., et al. Behçet's disease in southern Chinese patients. The Journal of Rheumatology 29 (2002) 1689-1693
17. Al-Rawi Z.S., and Neda A.H. Prevalence of Behçet's disease among Iraqis. Advances In Experimental Medicine and Biology 528 (2003) 37-41
18. Jaber L., Milo G., Halpern G.J., et al. Prevalence of Behçet's disease in an Arab community in Israel. Annals of the Rheumatic Diseases 61 (2002) 365-366
19. Papoutsis N.G., Abdel-Naser M.B., Altenburg A., et al. Prevalence of Adamantiades-Behçet's disease in Germany and the municipality of Berlin: results of a nationwide survey. Clinical and Experimental Rheumatology 24 5 Suppl. 42 (2006) S125
20. Salvarani C., Pipitone N., Catanoso M.G., et al. Epidemiology and clinical course of Behçet's disease in the Reggio Emilia area of Northern Italy: a seventeen-year population-based study. Arthritis and Rheumatism 57 (2007) 171-178
21. Wilson F.C., Icen M., Crowson C.S., et al. Incidence and prevalence of Behçet's disease in a north American population. Arthritis and Rheumatism 56 Suppl. (2007) abstract F 34
22. Mahr A.D., Belarbi L., Wechsler B., et al. Epidemiology of Behçet's disease in a multiethnic French population. Arthritis and Rheumatism 56 Suppl. (2007) abstract no 1244
23. Poon W., Verity D.H., Larkin G.L., et al. Behcet's disease in patients of West African and Afro-Caribbean origin. British Journal of Ophthalmology 87 (2003) 876-878
24. Shimizu T., Ehrlich G.E., Inaba G., and Hayashi K. Behçet disease (Behçet syndrome). Seminars in Arthritis and Rheumatism 8 (1979) 223-260
25. Yurdakul S., Tuzuner N., Yurdakul I., et al. Gastrointestinal involvement in Behçet's syndrome: a controlled study. Annals of the Rheumatic Diseases 55 (1996) 208-210
26. Yazi{dotless}ci{dotless} H., Chamberlain M.A., Tuzun Y., et al. A comparative study of the pathergy among Turkish and British patients with Behçet's disease. Annals of the Rheumatic Diseases 43 (1984) 74-75
27. Yazici H., Tuzun Y., Pazarli H., et al. Influence of age of onset and patient's sex on the prevalence and severity of manifestations of Behçet's syndrome. Annals of the Rheumatic Diseases 43 (1984) 783-789
28. Kone-Paut I., Yurdakul S., Bahabri S.A., et al. Clinical features of Behçet's disease in children: an international colloborative study of 86 cases. The Journal of Pediatrics 132 (1998) 721-725
29. Mat C., Göksugur N., Engin B., et al. The frequency of scarring after genital ulcers in Behçet's syndrome: a prospective study. International Journal of Dermatology 45 (2006) 554-556
30. Ergun T., Gurbuz O., Dogusoy G., et al. Histopathologic features of the spontaneous pustular lesions of Behçet's syndrome. International Journal of Dermatology 37 (1998) 194-196
31. Tüzün Y., Yazi{dotless}ci{dotless} H., Pazarli{dotless} H., et al. The usefulness of the nonspecific skin hyperreactivity (The pathergy test) in Behçet's disease in Turkey. Acta Dermatovener (Stockholm) 59 (1979) 77-79
32. Tugal-Tutkun I., Onal S., Altan-Yaycioglu R., et al. Uveitis in Behçet disease: an analysis of 880 patients. American Journal of Ophthalmology 138 (2004) 373-380
33. Behçet H., and Gozcu N. Uç nahiyede nuksi tavazzular yapan ve hususi bir virus tesiriyle umumi intan hasil ettigine kanaatimiz artan (Entite morbide) hakkinda. Deri Hastaliklari ve Frengi Kliniǧi Arsivi 5 (1938) 1863-1873 [in Turkish]
34. Yurdakul S., Yazici H., Tuzun Y., et al. The arthritis of Behçet's disease: a prospective study. Annals of the Rheumatic Diseases 42 (1983) 505-515
35. Yazici H., Tuzlaci M., and Yurdakul S. A controlled survey of sacroiliitis in Behçet's disease. Annals of the Rheumatic Diseases 40 (1981) 558-559
36. Diri E., Mat C., Hamuryudan V., et al. Papulopustular skin lesions are seen more frequently in patients with Behçet's syndrome who have arthritis: a controlled and masked study. Annals of the Rheumatic Diseases 60 (2001) 1074-1076
37. Hatemi G., Fresko I., Tascilar K., and Yazici H. Enthesopathy is increased among Behçet's syndrome patients with acne and arthritis: an ultrasonographic study. Arthritis and Rheumatism 58 5 (2008) 1539-1545
38. Muftuoglu A.U., Yurdakul S., Yazici H., et al. Vascular involvement in Behçet disease: a review of 129 cases. In: Lehner T., and Barnes C.G. (Eds). Recent advances in Behcet Disease (1986), Royal Society of Medicine Services Ltd, London 255-260
39. Lie J.T. Vascular involvement in Behçet's disease: arterial and venous and vessels of all sizes. The Journal of Rheumatology 19 (1992) 341-343
40. Koc Y., Gullu I., Akpek G., et al. Vascular involvement in Behçet's disease. The Journal of Rheumatology 19 (1992) 402-410
41. Sarica-Kucukoglu R., Akdag-Kose A., Kayabali M., et al. Vascular involvement in Behçet's disease: a retrospective analysis of 2319 cases. International Journal of Dermatology 45 (2006) 919-921
42. Düzgün N., Ateş A., Aydintuǧ O.T., et al. Characteristics of vascular involvement in Behçet's disease. Scandinavian Journal of Rheumatology 35 (2006) 65-68
43. Bayraktar Y., Ozaslan E., and Van Thiel D.H. Gastrointestinal manifestations of Behcet's disease. Journal of Clinical Gastroenterology 30 (2000) 144-154
44. Hamuryudan V., Yurdakul S., Moral F., et al. Pulmonary arterial aneurysms Behçet's syndrome: a report of 24 cases. British Journal of Rheumatology 33 (1994) 48-51
45. Hamuryudan V., Er T., Seyahi E., et al. Pulmonary artery aneurysms in Behçet syndrome. American Journal of Medicine 117 (2004) 867-870
46. Seyahi E., Melikoglu M., Akman C., et al. Pulmonary vascular involvement in Behçet's syndrome (BS). Arthritis and Rheumatism 56 Suppl. (2007) abstract no 853
47. Ozkan M., Emel O., Ozdemir M., et al. M-mode, 2-D and Doppler echocardiographic study in 65 patients with Behçet's syndrome. European Heart Journal 13 (1992) 638-641
48. Seyahi E., Ugurlu S., Cumali R., et al. Atherosclerosis in Behçet's syndrome. Seminars in Arthritis and Rheumatism 38 (2008) 1-12
49. Akman-Demir G., Serdaroglu P., and Tasci B. Clinical patterns of neurological involvement in Behçet's disease: evaluation of 200 patients. The Neuro-Behcet Study Group. Brain 122 (1999) 2171-2182
50. Siva A., Kantarci O.H., Saip S., et al. Behçet's disease: diagnostic and prognostic aspects of neurological involvement. Journal of Neurology 248 (2001) 95-103
51. Korman U., Cantasdemir M., Kurugoglu S., et al. Enteroclysis findings of intestinal Behcet disease: a comparative study with Crohn disease. Abdominal Imaging 28 (2003) 308-312
52. Melikoglu M., Altiparmak M.R., Fresko I., et al. A reappraisal of amyloidosis in Behçet's syndrome. Rheumatology (Oxford) 40 (2001) 212-215
53. Cetinel B., Akpinar H., Tufek I., et al. Bladder involvement in Behçet's syndrome. The Journal of Urology 161 (1999) 52-56
54. Melikoglu M., Kural-Seyahi E., Tascilar K., et al. The unique features of vasculitis in Behçet's syndrome. Clinical Reviews in Allergy & Immunology 35 (2008) 40-46
55. Kobayashi M., Ito M., Nakagawa A., et al. Neutrophil and endothelial cell activation in the vasa vasorum in vasculo-Behçet disease. Histopathology 36 (2000) 362-371
56. Melikoglu M., Uysal S., Kreuger J.G., et al. Characterization of the divergent wound-healing responses occurring in the pathergy reaction and normal healthy volunteers. Journal of Immunology 177 (2006) 6415-6421
57. Krause I., and Weinberger A. Behçet's disease. Current Opinion In Rheumatology 20 (2008) 82-87
58. Matsumoto T., Uekusa T., and Fukuda Y. Vasculo-Behçet's disease: a pathological study of eight cases. Human Pathology 22 (1991) 45-51
59. Lee K.H., Chung H.S., Kim H.S., et al. Human alpha-enolase from endothelial cells as a target antigen of anti-endothelial cell antibody in Behçet's disease. Arthritis and Rheumatism 48 (2003) 2025-2035
60. Okuniki Y., Usui Y., Takeuchi M., et al. Proteomic survey of Behçet's disease with uveitis: selenium binding protein is a novel autoantigen in Behçet's disease. Experimental Eye Research 84 (2007) 823-831
61. Dalghous A.M., Freysdottir J., Fortune F., et al. Expression of cytokines, chemokines and chemokine receptors in oral ulcers of pateints with Behçet's disease (BD) and recurrent aphthous stomatitis is Th1 associated, although Th2 association is also observed in patients with BD. Scandinavian Journal of Rheumatology 35 (2006) 472-475
62. Espinosa G., Font J., Tassies D., et al. Vascular involvement in Behçet's disease: relation with thrombophilic factors, coagulation activation, and thrombomodulin. The American Journal of Medicine 112 (2002) 37-43
63. Hatemi G., Bahar H., Uysal S., et al. The pustular skin lesions in Behçet's syndrome are not sterile. Annals of the Rheumatic Diseases 63 (2004) 1450-1452
64. Gul A., Inanç M., Ocal L., et al. Familial aggregation of Behçet's disease in Turkey. Annals of the Rheumatic Diseases 59 (2000) 622-625
65. Karasneh J., Gul A., Ollier W.E., et al. Whole-genome screening for susceptibility genes in multicase families with Behçet's disease. Arthritis and Rheumatism 52 (2005) 1836-1842
66. Gul A. Behçet's disease as an autoinflammatory disorder. Current Drug Targets. Inflammation and Allergy 4 (2005) 81-83
67. Yazici H., and Fresko I. Behçet's disease and other autoinflammatory conditions: what's in a name?. Clinical and Experimental Rheumatology 23 4 Suppl. 38 (2005) S1-S2
68. Ryan J.G., and Goldbach-Masky R. The spectrum of autoinflammatory disease: recent bench to bedside observations. Current Opinion in Rheumatology 20 (2008) 66-75
69. Çaki{dotless}r N., Yazi{dotless}ci{dotless} H., Chamberlain M.A., et al. Response to intradermal injection of monosodium urate crystals in Behçet's syndrome. Annals of the Rheumatic Diseases 50 (1991) 634-636
70. Tunc R., Saip S., Siva A., and Yazici H. Cerebral venous thrombosis is associated with major vessel disease in Behçet's syndrome. Annals of the Rheumatic Diseases 63 (2004) 1693-1694
71. Fresko I., Ugurlu S., Ozbakir F., et al. Anti-Saccharomyces cerevisiae antibodies (ASCA) in Behçet's syndrome. Clinical and Experimental Rheumatology 23 4 Suppl. 38 (2005) S67-S70
72. Muftuoglu A.U., Yazici H., Yurdakul S., et al. Behçet's disease. Relation of serum C-reactive protein and erythrocyte sedimentation rates to disease activity. International Journal of Dermatology 25 (1986) 235-239
73. International Study Group for Behçet's Disease. Criteria for diagnosis of Behçet's disease. Lancet 335 (1990) 1078-1080
74. O'Duffy J.D. Suggested criteria for diagnosis of Behcet's disease. The Journal of Rheumatology 1 Suppl. 1 (1974) Abstr 32:18
75. Mason R.M., and Barnes C.G. Behcet's syndrome with arthritis. Annals of the Rheumatic Diseases 28 (1969) 95-103
76. Behçet's Disease Research Committee of Japan. Behçet's disease: guide to diagnosis of Behçet's disease. Japanese Journal of Ophthalmology 18 (1974) 291-294
77. Dilsen N, Konice M, Aral O. Our diagnostic criteria of Behcet's disease-an overview. In: T Lehner (ed) Recent advances in Behcet's Disease. International Congress Series pp 177-180, 1986.
78. Cheng Zhang X.-Q. Chinese Journal of Internal Medicine 19 (1980) 15-20 [in Chinese]
79. O'Neill T.W., Rigby A.S., Silman A.J., and Barnes C.G. Validation of the International Study Group criteria for Behcet's disease. British Journal of Rheumatology 33 (1994) 115-117
80. Tunc R., Uluhan A., Melikoglu M., et al. A reassessment of the International Study Group criteria for the diagnosis (classification) of Behçet's syndrome. Clinical and Experimental Rheumatology 19 5 Suppl. 24 (2001) S45-S47
81. Kural-Seyahi E., Fresko I., Seyahi N., et al. The long-term mortality and morbidity of Behçet syndrome: a 2-decade outcome survey of 387 patients followed at a dedicated center. Medicine (Baltimore) 82 (2003) 60-76
82. Aktulga E., Altac M., Muftuoglu A., et al. A double blind study of colchicine in Behçet's disease. Haematologica 65 (1980) 399-402
83. Yurdakul S., Mat C., Tuzun Y., et al. A double-blind trial of colchicine in Behçet's syndrome. Arthritis and Rheumatism 44 (2001) 2686-2692
84. Yazici H., Pazarli H., Barnes C.G., et al. A controlled trial of azathioprine in Behçet's syndrome. The New England Journal of Medicine 322 (1990) 281-285
85. Hamuryudan V., Ozyazgan Y., Hizli N., et al. Azathioprine in Behçet's syndrome: effects on long-term prognosis. Arthritis and Rheumatism 40 (1997) 769-774
86. Hamuryudan V., Ozyazgan Y., Fresko Y., et al. Interferon alfa combined with azathioprine for the uveitis of Behçet's disease: an open study. The Israel Medical Association journal: IMAJ 4 11 Suppl (2002) 928-930
87. Masuda K., Nakajima A., Urayama A., et al. Double-masked trial of cyclosporin versus colchicine and long-term open study of cyclosporin in Behçet's disease. Lancet 333 (1989) 1093-1096
88. Hamuryudan V., Mat C., Saip S., et al. Thalidomide in the treatment of the mucocutaneous lesions of the Behçet syndrome. A randomized, double-blind, placebo-controlled trial. Annals of Internal Medicine 128 (1998) 443-450
89. Moral F., Hamuryudan V., Yurdakul S., and Yazici H. Inefficacy of azapropazone in the acute arthritis of Behçet's syndrome: a randomized, double blind, placebo controlled study. Clinical and Experimental Rheumatology 13 (1995) 493-495
90. Alpsoy E., Durusoy C., Yilmaz E., et al. Interferon alfa-2a in the treatment of Behçet disease: a randomized placebo-controlled and double-blind study. Archives of Dermatology 138 (2002) 467-471
91. Sfikakis P.P., Markomichelakis N., Alpsoy E., et al. Anti-TNF therapy in the management of Behcet's disease-review and basis for recommendations. Rheumatology (Oxford) 46 (2007) 736-741
92. Melikoglu M., Fresko I., Mat C., et al. Short-term trial of etanercept in Behçet's disease: a double blind, placebo controlled study. The Journal of Rheumatology 32 (2005) 98-105
93. Mat C., Yurdakul S., Uysal S., et al. Double-blind trial of depot corticosteroids in Behçet's syndrome. Rheumatology (Oxford) 45 (2006) 348-352
94. Denman A.M., Hollingworth P., Webster A.D.B., et al. Failure of transfer factor in the treatment of Behçet's syndrome: a double-blind trial. In: Lehner T., and Barnes C.G. (Eds). Behçet's Syndrome (1979), Academic Press, London 227-289
95. Davies U.M., Palmer R.G., and Denman A.M. Treatment with acyclovir does not affect orogenital ulcers in Behcet's syndrome: a randomized double-blind trial. British Journal of Rheumatology 27 (1988) 300-302
96. Buggage R.R., Levy-Clarke G., Sen H.N., et al. A double-masked, randomized study to investigate the safety and efficacy of daclizumab to treat the ocular complications related to Behçet's disease. Ocular Immunology and Inflammation 15 (2007) 63-70
97. Sharquie K.E., Najim R.A., and Abu-Raghif A.R. Dapsone in Behçet's disease: a double-blind, placebo-controlled, cross-over study. The Journal of Dermatology 29 (2002) 267-279
98. Hatemi G, Silman A, Bang D, et al. EULAR recommendations for the management of Behçet's disease: report of a task force of the European Standing Committee for International Clinical Studies Including Therapeutics (ESCISIT). Annals of the Rheumatic Diseases, in press.